ACRS
Aclaris Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -12.5% ·
share flow -7.9% ·
net new positions -14.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | -2 | 41.91M | $221.50M | +3 | −6 |
| Q1 2026 | 65 | -2 | 41.75M | $156.42M | +5 | −7 |
| Q4 2025 | 67 | +2 | 40.44M | $121.72M | +2 | — |
| Q3 2025 | 17 | +1 | 36.82M | $69.96M | +1 | — |
| Q2 2025 | 13 | 0 | 38.17M | $54.21M | — | — |
| Q1 2025 | 10 | 0 | 23.63M | $36.15M | — | — |
| Q4 2024 | 10 | +2 | 20.49M | $50.82M | +2 | — |
| Q3 2024 | 7 | -1 | 10.01M | $11.51M | — | −1 |
| Q2 2024 | 8 | — | 10.87M | $11.95M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 3.37M | +1.6% | $3.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Millennium Management ✦ | 3.01M | -9.9% | $3.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.37M | +48.6% | $1.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 907.92K | -18.4% | $1.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 846.45K | +9.3% | $973,577 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 364.57K | -58.4% | $419,252 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 139.40K | 0.0% | $161,000 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| AQR Capital Management | $424,795 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 135 holders, 108.23M shares, $397.63M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.